Merit Medical Systems Aktie
WKN: 882361 / ISIN: US5898891040
06.05.2025 15:57:18
|
Merit Medical Systems Says Health Canada Approved Wrapsody Cell-Impermeable Endoprosthesis
(RTTNews) - Merit Medical Systems, Inc. (MMSI), a healthcare technology company, Tuesday said that its Wrapsody Cell-Impermeable Endoprosthesis (CIE) received approval from Health Canada.
Cell-Impermeable Endoprosthesis is a device typically used in hemodialysis patients to help in treating stenosis or narrowing of blood vessels. The Wrapsody CIE was developed to treat patients on hemodialysis who experience vascular access stenosis.
The approval was supported by positive results from the Wrapsody Arteriovenous Access Efficacy (WAVE) study.
The company said it plans to begin immediate commercialization of the device throughout Canada.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Merit Medical Systems Inc.mehr Nachrichten
Analysen zu Merit Medical Systems Inc.mehr Analysen
Aktien in diesem Artikel
Merit Medical Systems Inc. | 70,50 | 2,17% |
|